Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe

The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal...

Descripción completa

Detalles Bibliográficos
Autores principales: Stranix-Chibanda, L., Brummel, S., Pilotto, J., Mutambanengwe, M., Chanaiwa, V., Mhembere, T., Kamateeka, M., Aizire, J., Masheto, G., Chamanga, R., Maluwa, M., Hanley, S., Joao, E., Theron, G., Nevrekar, N., Nyati, M., Santos, B., Aurpibul, L., Mubiana-Mbewe, M., Oliveira, R., Anekthananon, T., Mlay, P., Angelidou, K., Tierney, C., Ziemba, L., Coletti, A., McCarthy, K., Basar, M., Chakhtoura, N., Browning, R., Currier, J., Fowler, M. G., Flynn, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766470/
https://www.ncbi.nlm.nih.gov/pubmed/31399793
http://dx.doi.org/10.1007/s10461-019-02624-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766470/
https://www.ncbi.nlm.nih.gov/pubmed/31399793
http://dx.doi.org/10.1007/s10461-019-02624-3

Ejemplares similares